Top compounds associated with response to LMNTD1


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.062 0.05
mRNA CIL55A CTRPv2 pan-cancer AAC 0.092 0.06
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.094 0.06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.06
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC -0.069 0.06
mRNA AZD7762 GDSC1000 pan-cancer AAC 0.061 0.06
mRNA AR-42 GDSC1000 pan-cancer AAC 0.056 0.06
mRNA AM-580 CTRPv2 pan-cancer AAC -0.067 0.06
mRNA Mdivi-1 CTRPv2 pan-cancer AAC 0.066 0.06
mRNA ML162 CTRPv2 pan-cancer AAC 0.061 0.06
Download CSV